GSK Investigational Site — Cranston, Rhode Island

GSK Investigational Site is a clinical research site located in Cranston, Rhode Island, United States 02920.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

GSK Investigational Site has participated in 6 clinical trials.

Therapeutic areas: Neoplasms, Prostate, Pulmonary Disease, Chronic Obstructive, Bowel Dysfunction.

Sponsors: GlaxoSmithKline, Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GSK Investigational Site?

GSK Investigational Site has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GSK Investigational Site conducted?

GSK Investigational Site has 6 clinical trials on record. Their work covers Neoplasms, Prostate, Pulmonary Disease, Chronic Obstructive, Bowel Dysfunction.

Is GSK Investigational Site accredited by Crixeo Health?

GSK Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GSK Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.